{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T15:11:07Z","timestamp":1688915467260},"reference-count":56,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,1]]},"abstract":"<jats:p>Precocious pubarche in girls is often preceded by low weight at birth and followed by hirsutism, ovarian hyperandrogenism, and oligomenorrhea in adolescence, the latter usually being accompanied by dyslipidemia and hyperinsulinism, which are, in turn, two major risk factors for cardiovascular disease in later life. We hypothesized that insulin resistance may be a key pathogenetic factor in this sequence.<\/jats:p><jats:p>We tested the hypothesis by assessing the effects of an insulin-sensitizing agent, metformin, given at a daily dose of 1275 mg for 6 months to 10 nonobese adolescent girls (mean age, 16.8 yr; body mass index, 21.9 kg\/m2; birth weight, 2.7 kg) with hirsutism, ovarian hyperandrogenism (diagnosis by GnRH agonist test), oligomenorrhea, dyslipidemia, and hyperinsulinemia after precocious pubarche. Before the metformin trial, longitudinal studies in these girls had shown that hyperinsulinism was present at prepubertal diagnosis of precocious pubarche, and that it increased markedly in late puberty or early postmenarche.<\/jats:p><jats:p>Metformin treatment was well tolerated and was accompanied by a marked drop in hirsutism score, insulin response to oral glucose tolerance test, free androgen index, and baseline testosterone, androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfate levels (all P &amp;lt; 0.01). During metformin treatment, the LH and 17-hydroxyprogesterone hyperresponses to GnRH agonist were attenuated (P &amp;lt; 0.01); serum triglyceride, total cholesterol, and low density lipoprotein cholesterol levels decreased; and high density lipoprotein cholesterol rose. All girls reported regular menses within 4 months. Withdrawal of metformin treatment was followed, within 3 months, by a consistent reversal toward pretreatment conditions.<\/jats:p><jats:p>In conclusion, metformin treatment reduced hyperinsulinemia, hirsutism, and hyperandrogenism; attenuated the LH and 17hydroxyprogesterone hyperresponses to GnRH agonist; improved the atherogenic lipid profile; and restored eumenorrhea in nonobese adolescent girls with a history of precocious pubarche. These observations corroborate the idea that insulin resistance may indeed be a prime factor underpinning the sequence from reduced fetal growth, through precocious pubarche, to adolescent endocrinopathies that are reminiscent of so-called polycystic ovary syndrome.<\/jats:p>","DOI":"10.1210\/jcem.85.10.6908","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:10Z","timestamp":1389200710000},"page":"3526-3530","source":"Crossref","is-referenced-by-count":1,"title":["Sensitization to Insulin in Adolescent Girls to Normalize Hirsutism, Hyperandrogenism, Oligomenorrhea, Dyslipidemia, and Hyperinsulinism after Precocious Pubarche1"],"prefix":"10.1210","volume":"85","author":[{"given":"Lourdes","family":"Iba\u0301n\u0303ez","sequence":"first","affiliation":[{"name":"Endocrinology Unit (L.I.), University of Barcelona, 08950 Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Valls","sequence":"additional","affiliation":[{"name":"Hormonal Laboratory (C.V.), Hospital Sant Joan de De\u0301u, University of Barcelona, 08950 Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Potau","sequence":"additional","affiliation":[{"name":"Hormonal Laboratory, Hospital Materno-Infantil Vall d\u2019Hebron, Autonomous University of Barcelona (N.P.), 08035 Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Victoria","family":"Marcos","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Consorci Hospitalari de Terrassa (M.V.M.), 08227 Terrassa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"de Zegher","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Leuven (F.d.Z.), 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071617383546200_R1","article-title":"Androgens in adrenarche and pubarche. In: Azziz R, Nestler JE, Dewailly D, eds","author":"Iba\u0301n\u0303ez","year":"1997"},{"key":"2020071617383546200_R2","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth.","volume":"83","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/edrv-16-3-322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.","volume":"16","author":"Ehrman","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071617383546200_R4","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence.","volume":"84","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R5","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased incidence of functional ovarian hyperandrogenism.","volume":"76","author":"Iba\u0301n\u0303ez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R6","first-page":"2283","article-title":"Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche.","volume":"82","author":"Iba\u0301n\u0303ez","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s001250051030","article-title":"Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche.","volume":"41","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"Diabetologia"},{"key":"2020071617383546200_R8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease.","volume":"334","author":"Despre\u0301s","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071617383546200_R9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00403180","article-title":"Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome.","volume":"34","author":"Ferrannini","year":"1991","journal-title":"Diabetologia"},{"key":"2020071617383546200_R10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.ATV.17.1.107","article-title":"Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men.","volume":"17","author":"Goldbourt","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071617383546200_R11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.83.1.4500","article-title":"Hormonal effects of flutamide in young women with polycystic ovary syndrome.","volume":"83","author":"Leo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R12","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","article-title":"The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.","volume":"83","author":"Diamanti-Kandarakis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R13","first-page":"3251","volume":"85","author":"Iba\u0301n\u0303ez","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0026-0495(95)90062-4","article-title":"Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.","volume":"44","author":"Diamanti-Kandarakis","year":"1995","journal-title":"Metabolism"},{"key":"2020071617383546200_R15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","article-title":"A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.","volume":"84","author":"Venturoli","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016294","article-title":"Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.","volume":"15","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"2020071617383546200_R17","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071617383546200_R18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jcem-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism.","volume":"62","author":"Barbieri","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0039-128X(96)00223-1","article-title":"Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells.","volume":"62","author":"Kristiansen","year":"1997","journal-title":"Steroids"},{"key":"2020071617383546200_R20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071617383546200_R21","first-page":"881","article-title":"Insulin infusion amplifies 17\u03b1-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20 lyase activity.","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/jcem-66-2-266","article-title":"Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.","volume":"66","author":"Suikkari","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0026-0495(90)90309-Z","article-title":"Regulation of sex hormone-binding globulin production by growth factors.","volume":"39","author":"Plymate","year":"1990","journal-title":"Metabolism"},{"key":"2020071617383546200_R24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduced hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.","volume":"43","author":"Vela\u0301zquez","year":"1994","journal-title":"Metabolism"},{"key":"2020071617383546200_R25","first-page":"4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17\u03b1 activity and serum androgens.","volume":"82","author":"Nestler","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R26","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R27","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"2020071617383546200_R28","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(98)00454-3","article-title":"Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.","volume":"71","author":"Hasegawa","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071617383546200_R30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0015-0282(16)58266-1","article-title":"Can metformin reduce insulin resistance in polycystic ovary syndrome?","volume":"65","year":"1996","journal-title":"Fertil Steril"},{"key":"2020071617383546200_R31","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil Steril"},{"key":"2020071617383546200_R33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2265.1999.00786.x","article-title":"The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.","volume":"51","author":"U\u0308nlu\u0308hizarci","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617383546200_R34","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R35","first-page":"1778","volume":"79","author":"Iba\u0301n\u0303ez","year":"1994"},{"key":"2020071617383546200_R36"},{"key":"2020071617383546200_R37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpedi.1991.02160030027015","article-title":"Standardized percentile curves of body mass index for children and adolescents.","volume":"145","author":"Hammer","year":"1991","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2020071617383546200_R38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.","volume":"56","author":"New","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R39","first-page":"3961","article-title":"Studies of 3\u03b2-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated \u03945-steroid levels.","volume":"81","author":"Sakkal-Alkaddour","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R40","article-title":"Insulin resistance: classification, prevalence, clinical manifestations, and diagnosis. In: Azziz R, Nestler JE, Dewailly D, eds","author":"Vidal-Puig","year":"1997"},{"key":"2020071617383546200_R41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/eje.0.1410027","article-title":"Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by gonadotropin-releasing hormone agonist challenge.","volume":"141","author":"Potau","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071617383546200_R42","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"2020071617383546200_R43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Drug therapy. Metformin.","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071617383546200_R44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0006-2952(97)00540-6","article-title":"Stimulation of the intracellular portion of the human insulin receptor by the antidiabetic drug metformin.","volume":"55","author":"Stith","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"2020071617383546200_R45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R46","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/humrep\/14.12.2951","article-title":"Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinemia or lean normoinsulinemia.","volume":"14","author":"Ciotta","year":"1999","journal-title":"Hum Reprod"},{"key":"2020071617383546200_R47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(99)00407-0","article-title":"Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome.","volume":"72","author":"La Marca","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071617383546200_R48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1530\/eje.0.1400056","article-title":"The treatment of insulin resistance does not improve adrenal cytochrome P450c17\u03b1 enzyme dysregulation in polycystic ovary syndrome.","volume":"140","author":"U\u0308nlu\u0308hizarci","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071617383546200_R49","first-page":"878","article-title":"Editorial: evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved.","volume":"81","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R50","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1210\/jcem.84.9.5953","article-title":"Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans.","volume":"84","author":"Fruehwald-Schultes","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pitutary cells.","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"2020071617383546200_R52","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617383546200_R53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.ATV.10.2.223","article-title":"Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance.","volume":"10","author":"Laakso","year":"1990","journal-title":"Arteriosclerosis"},{"key":"2020071617383546200_R54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein (a) and immunoreactive insulin levels in patients with polycystic ovary syndrome.","volume":"46","author":"Vela\u0301zquez","year":"1997","journal-title":"Metabolism"},{"key":"2020071617383546200_R55","first-page":"319","article-title":"Hypofibrinolytic amd atherogenic risk factors for stroke.","volume":"125","author":"Glueck","year":"1995","journal-title":"J Lab Clin Med"},{"key":"2020071617383546200_R56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1203\/00006450-199909000-00012","article-title":"Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth.","volume":"46","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"Pediatr Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/10\/3526\/10401534\/jcem3526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/10\/3526\/10401534\/jcem3526.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:56:14Z","timestamp":1688914574000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/10\/3526\/2851442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.10.6908","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,1]]}}}